Literature DB >> 10211329

Increased serum CA 19-9 antibodies in Sjögren's syndrome.

R Safadi1, M Ligumsky, E Goldin, Y Ilan, Y S Haviv, S Nusair.   

Abstract

A 67-year-old woman with a history of thyroiditis presented with recent intermittent epigastric pain and nausea. Hyperamylasaemia, oedema of the pancreas, and high serum levels of lipase and CA 19-9 were found. Xerostomia and dry eyes developed later, accompanied by an abnormal Schirmer's test. The diagnosis of Sjögren's syndrome was confirmed by increased anti-Ro and anti-La antibodies and the histological findings of parotid gland biopsy. Two additional cases of Sjögren's syndrome with elevated serum CA 19-9 are also described. These observations of elevated serum lipase and serum CA 19-9 in Sjögren's syndrome without evidence of malignancy may reflect pancreatic involvement in this disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10211329      PMCID: PMC2361055          DOI: 10.1136/pgmj.74.875.543

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

Review 1.  CA 50 and CA 19-9 in serum as tumor markers for pancreatic cancer: a review of the literature.

Authors:  A Andrén-Sandberg
Journal:  Acta Chir Scand Suppl       Date:  1989

2.  Salivary amylase and pancreatic enzymes in Sjögren's syndrome.

Authors:  B Pal; I D Griffiths; A Katrak; D Junglee; P Dandona
Journal:  Clin Chem       Date:  1987-02       Impact factor: 8.327

Review 3.  Sjögren's syndrome and the gut.

Authors:  E V Tsianos; H M Moutsopoulos
Journal:  Baillieres Clin Rheumatol       Date:  1989-08

Review 4.  Sjögren's syndrome.

Authors:  R Manthorpe; L T Jacobsson
Journal:  Baillieres Clin Rheumatol       Date:  1995-08

5.  [Increase of CA 19.9 in dysimmune inflammatory rheumatism. Apropos of 6 cases].

Authors:  A Cantagrel; L Moulinier; K Beljio; M Duffaut; M Laroche; E Bon; B Mazières
Journal:  Rev Rhum Ed Fr       Date:  1994-10

6.  The gastrointestinal involvement in primary Sjögren's syndrome.

Authors:  E B Tsianos; S Vasakos; A A Drosos; V D Malamou-Mitsi; H M Moutsopoulos
Journal:  Scand J Rheumatol Suppl       Date:  1986

7.  Elevated serum CA125 in progressive systemic sclerosis with pleural effusion.

Authors:  K Kimura; K Ezoe; H Yokozeki; I Katayama; K Nishioka
Journal:  J Dermatol       Date:  1995-01       Impact factor: 4.005

8.  Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer.

Authors:  D K Pleskow; H J Berger; J Gyves; E Allen; A McLean; D K Podolsky
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391

Review 9.  Pulmonary and gastrointestinal manifestations of Sjögren's syndrome.

Authors:  S H Constantopoulos; E V Tsianos; H M Moutsopoulos
Journal:  Rheum Dis Clin North Am       Date:  1992-08       Impact factor: 2.670

10.  Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins.

Authors:  J J Ho; K Norton; Y S Chung; Y S Kim
Journal:  Oncol Res       Date:  1993       Impact factor: 5.574

  10 in total
  4 in total

Review 1.  Elevated CA 19-9 caused by Hashimoto's thyroiditis: review of the benign causes of increased CA 19-9 level.

Authors:  Javier L Parra; Steven Kaplan; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

2.  A case of raised CA 19-9 in a patient with desmoplastic fibroblastoma of the upper limb.

Authors:  Kumaran Rasappan; Leanne Kayla Rebecca Mei-Yi Shaw; Lester Wai Mon Chan; Khoon Leong Chuah; Mathew Hern Wang Cheng
Journal:  Int Cancer Conf J       Date:  2021-04-24

3.  Carbohydrate 19.9 antigen serum levels in liver disease.

Authors:  Gaetano Bertino; Annalisa Maria Ardiri; Giuseppe Stefano Calvagno; Giulia Malaguarnera; Donatella Interlandi; Marco Vacante; Nicoletta Bertino; Francesco Lucca; Roberto Madeddu; Massimo Motta
Journal:  Biomed Res Int       Date:  2013-10-27       Impact factor: 3.411

Review 4.  Aquaporins in Salivary Glands: From Basic Research to Clinical Applications.

Authors:  Christine Delporte; Angélic Bryla; Jason Perret
Journal:  Int J Mol Sci       Date:  2016-01-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.